Opendata, web and dolomites


Computer Aided Multispectral Ulstrasound Diagnostic Device

Total Cost €


EC-Contrib. €






 UltraEASY project word cloud

Explore the words cloud of the UltraEASY project. It provides you a very rough idea of what is the project "UltraEASY" about.

diagnostics    version    invasive    billion    someone    immense    wake    every    diagnosis    sonovum    acute    brain    vehicles    events    computer    acquisition    36    ing    camud    amounts    examination    fast    basic    suited    patients    acoustics    mobile    monitoring    continuous    stroke    diagnosing    multispectral    practices    daily    vitals    first    acceptance    health    frame    tissue    europeans    incidents    trade    flexibility    groups    diagnose    units    things    small    feedback    diagnostic    modern    global    therewith    suffers    economic    ultrasound    waves    carriers    family    validation    damage    ambulances    helicopters    eur    feasibility    realization    mobility    physicians    strategies    risk    precise    molecular    initial    seconds    conclude    patient    beginning    underlying    clinical    ultraeasy    medtech    evaluation    final    therapeutic    rescue    regard    insurance    time    2006    innovation    conduct    harmful    thanks    stands    aided    multiple    specialist    ag    killing    clinics    neuropathologies    emergency    market    markets    frequencies    interpretable    preventatively   

Project "UltraEASY" data sheet

The following table provides information about the project.


Organization address
postcode: 4103
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2015-10-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SONOVUM AG DE (LEIPZIG) coordinator 50˙000.00


 Project objective

Every 40 seconds, someone in Europe suffers from a stroke killing 1,000 Europeans daily. The resulting economic damage is immense. In the 2006 wake-up-study funded by the EU the economic damage in Europe amounts to 36 billion EUR per year. The objective of this project is the clinical validation of SoNovum AG’s UltraEASY™ II Brain Vitals Monitoring System and the underlying CAMUD technology for diagnosing and monitoring neuropathologies in acute events and at-risk patient groups. CAMUD stands for “Computer Aided Multispectral Ultrasound Diagnostics” and is a novel diagnostic method based on molecular acoustics. It measures the feedback of ultrasound waves on multiple frequencies, which is interpretable for the first time thanks to modern computer technology. The technology enables, among other things, a fast, very precise and non-invasive diagnosis of the brain tissue in the beginning of the therapeutic time frame as well as further, continuous monitoring. Therewith physicians will be able to diagnose acute events more quickly and preventatively at-risk patient groups, even before harmful incidents occur. Initial target market groups for UltraEASY II include the stroke units in clinics as well as family and specialist's practices in Europe with regard to global markets as well. Because of high mobility, flexibility and the small acquisition costs, it is well suited as basic equipment for practices as well as, in its mobile version, for helicopters, rescue vehicles and ambulances of clinics and emergency organizations. The objectives of this Feasibility Study are the examination of the market acceptance towards UltraEASY II, addressing clinics and physicians as well as involving patients, patient organizations and health insurance carriers, in order to conduct the risk evaluation for the final realization of the CAMUD technology in the MedTech sector and conclude the development of final innovation strategies for Phase 2.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ULTRAEASY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ULTRAEASY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

RESHAPE (2019)

Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials

Read More  

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

ESCALON (2019)

European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development

Read More